In a 17‑week pregnant patient, is amoxicillin or cephalexin the preferred antibiotic for treating a urinary tract infection?

Cephalexin is the Preferred Antibiotic for UTI at 17 Weeks Pregnancy

Cephalexin should be prescribed over amoxicillin for treating urinary tract infections in the second trimester of pregnancy, because amoxicillin alone has very high worldwide resistance rates and should not be used for complicated UTIs, whereas cephalexin maintains better efficacy and is FDA-approved for genitourinary infections caused by susceptible organisms. 1

Why Amoxicillin Alone Should Be Avoided

• Amoxicillin or ampicillin monotherapy should not be used for complicated UTIs because worldwide resistance to these agents is very high, making treatment failure likely. 1
• Pregnancy automatically classifies a UTI as complicated due to the physiological changes and potential for maternal-fetal complications, requiring broader antimicrobial coverage than simple amoxicillin provides. 1, 2

Cephalexin as the Preferred Agent

• The FDA label authorizes cephalexin for treatment of genitourinary infections when the isolate is susceptible, and it should be guided by urine culture and susceptibility testing. 3
• Cephalexin 500 mg orally four times daily for 7 days is an appropriate regimen for UTI in pregnancy, based on historical evidence showing efficacy in pregnant women with bacteriuria. 4
• First- and second-generation cephalosporins like cephalexin provide adequate coverage for common uropathogens (E. coli, Klebsiella, Proteus) that cause UTIs in pregnancy. 1

Treatment Duration and Monitoring

• A 7-day course is recommended for symptomatic UTI in pregnancy, as shorter courses may be inadequate for complicated infections. 5, 6
• Obtain a urine culture before initiating therapy to enable targeted treatment, as pregnant women may harbor organisms with varying resistance patterns. 1, 5, 2
• Repeat urine culture 7 days following therapy to assess cure or failure, as recurrent infection is common in pregnancy. 7

Alternative First-Line Options When Cephalexin Cannot Be Used

• Nitrofurantoin 100 mg twice daily for 5-7 days is an excellent alternative for lower UTI in pregnancy, with high susceptibility rates and proven safety. 8, 2, 9
• Amoxicillin-clavulanate (not amoxicillin alone) can be considered if the pathogen is susceptible, as the addition of clavulanate overcomes resistance mechanisms. 1
• Fosfomycin 3 grams as a single dose is another option for uncomplicated lower UTI, though data in pregnancy are more limited. 2

Critical Safety Considerations in Pregnancy

• Avoid trimethoprim-sulfamethoxazole in the first trimester due to increased risk of congenital malformations, including severe cardiac defects (RR 2.09) and cleft lip/palate (RR 3.23) compared to β-lactams. 9
• Fluoroquinolones should generally be avoided during pregnancy because of potential cartilage toxicity in the developing fetus, though they may be considered in severe infections when alternatives are unsuitable. 1, 2
• Nitrofurantoin should be avoided near term (after 36 weeks) due to risk of hemolytic anemia in the newborn, but is safe in the second trimester. 2

When to Escalate to Parenteral Therapy

• If the patient develops systemic signs (fever, rigors, flank pain suggesting pyelonephritis), initiate hospital-based parenteral therapy with ceftriaxone 1-2 g IV once daily or a second-generation cephalosporin. 5, 2
• Aminoglycosides can be added as a second option in the second and third trimester for severe infections, though they carry nephrotoxicity and ototoxicity risks. 5

Common Pitfalls to Avoid

• Do not prescribe amoxicillin monotherapy for any UTI in pregnancy, as resistance rates make failure highly likely. 1
• Do not use short 3-day courses that are appropriate for uncomplicated cystitis in non-pregnant women; pregnancy requires 7-day therapy. 5, 7, 6
• Do not omit the follow-up urine culture after treatment, as asymptomatic bacteriuria can persist and lead to pyelonephritis if untreated. 7
• Ensure the patient completes the full 7-day course even if symptoms resolve earlier, to prevent recurrence and resistance development. 3